Compounds > triamterene
Page last updated: 2024-08-16

triamterene and bibw 22

triamterene has been researched along with bibw 22 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamberger, U; Boven, E; Heckel, A; Jansen, WJ; Kuiper, CM; Lincke, C; Pinedo, HM1
Bamberger, U; Chen, HX; Cheng, YC; Guo, X; Heckel, A1
Bamberger, U; Dieckmann-Schuppert, A; Schwarz, RT1
Bamberger, U; Esteban, M; Heckel, A; Kasimir-Bauer, S; Müller, MR; Scheulen, ME; Schröder, J; Seeber, S1
Bamberger, U; Boven, E; Feller, N; Jansen, WJ; Pinedo, HM; van der Wilt, CL1
Bamberger, U; Georges, E; Heckel, A; Lheureux, F; Liu, Z; Pouliot, JF1

Other Studies

6 other study(ies) available for triamterene and bibw 22

ArticleYear
Biochemical modulation of 'classical' multidrug resistance by BIBW22BS, a potent derivative of dipyridamole.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:8

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dipyridamole; Doxorubicin; Drug Resistance, Multiple; Female; Humans; Mice; Mice, Nude; Morpholines; Neoplasm Transplantation; Neoplasms, Experimental; Triamterene; Tumor Cells, Cultured; Vincristine

1994
BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport.
    Cancer research, 1993, May-01, Volume: 53, Issue:9

    Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Membrane Permeability; Dipyridamole; Drug Synergism; Fluorouracil; Humans; Membrane Glycoproteins; Morpholines; Nucleosides; Photochemistry; Thymidine; Triamterene; Tumor Cells, Cultured; Vincristine

1993
Chloroquine resistance in Plasmodium falciparum is not reversed by BIBW-22, a compound reversing the multidrug resistance phenotype in mammalian cancer cells.
    Biochemical pharmacology, 1993, Oct-19, Volume: 46, Issue:8

    Topics: Animals; Cell Survival; Chloroquine; Drug Resistance; Microbial Sensitivity Tests; Morpholines; Phenotype; Plasmodium falciparum; Triamterene; Tumor Cells, Cultured

1993
Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo.
    Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:5

    Topics: Antigens, CD34; Daunorubicin; Drug Resistance, Multiple; Humans; Idarubicin; Leukemia, Myeloid, Acute; Morpholines; Rhodamine 123; Rhodamines; Triamterene

1996
The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Deoxycytidine; Dipyridamole; Doxorubicin; Drug Resistance; Female; Floxuridine; Fluorouracil; Gemcitabine; Humans; Methotrexate; Mice; Mice, Nude; Morpholines; Neoplasms; Neoplasms, Experimental; Protein Binding; Transplantation, Heterologous; Triamterene; Tumor Cells, Cultured; Vincristine

1995
BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
    Molecular pharmacology, 1996, Volume: 50, Issue:3

    Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding Sites; Cell Line; Cell Survival; CHO Cells; Colchicine; Cricetinae; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Humans; Kinetics; Lymphoma; Morpholines; Peptide Mapping; Protein Binding; Triamterene; Tumor Cells, Cultured; Verapamil; Vinblastine

1996